Miyoun Yoo - Search Results

Year	Number of Results
2008	2
2010	1
2011	2
2012	1
2013	2
2015	1
2017	2
2018	3
2021	3
2022	1
2023	1
2024	0

1

Biotechnological Potential of Rhodococcus Biodegradative Pathways.

Kim D, Choi KY, Yoo M, Zylstra GJ, Kim E. Kim D, et al. Among authors: yoo m. J Microbiol Biotechnol. 2018 Jul 28;28(7):1037-1051. doi: 10.4014/jmb.1712.12017. J Microbiol Biotechnol. 2018. PMID: 29913546 Free article. Review.

2

Discovery of BET specific bromodomain inhibitors with a novel scaffold.

Pandit N, Yoo M, Hyun Park T, Kim J, Mi Kim S, Myung Lee K, Kim Y, Min Bong S, Il Lee B, Jung KY, Hoon Park C. Pandit N, et al. Among authors: yoo m. Bioorg Med Chem. 2022 Oct 15;72:116967. doi: 10.1016/j.bmc.2022.116967. Epub 2022 Aug 23. Bioorg Med Chem. 2022. PMID: 36099719

3

Novel brd4 inhibitors with a unique scaffold exhibit antitumor effects.

Kim YH, Kim M, Kim JE, Yoo M, Lee HK, Lee CO, Yoo M, Jung KY, Kim Y, Choi SU, Park CH. Kim YH, et al. Among authors: yoo m. Oncol Lett. 2021 Jun;21(6):473. doi: 10.3892/ol.2021.12734. Epub 2021 Apr 14. Oncol Lett. 2021. PMID: 33907583 Free PMC article.

4

Toxicity of the recombinant human hyaluronidase ALT-BC4 on embryonic development.

Lee JH, Yoo M, Lee SM, Park SJ, Kil TY, Kim MK. Lee JH, et al. Among authors: yoo m. J Anim Sci Technol. 2021 Mar;63(2):272-280. doi: 10.5187/jast.2021.e34. Epub 2021 Mar 31. J Anim Sci Technol. 2021. PMID: 33987603 Free PMC article.

5

Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study.

Kim JH, Pandit N, Yoo M, Park TH, Choi JU, Park CH, Jung KY, Lee BI. Kim JH, et al. Among authors: yoo m. Sci Rep. 2023 Jul 4;13(1):10805. doi: 10.1038/s41598-023-37527-w. Sci Rep. 2023. PMID: 37402749 Free PMC article.

6

Trisindoline synthesis and anticancer activity.

Yoo M, Choi SU, Choi KY, Yon GH, Chae JC, Kim D, Zylstra GJ, Kim E. Yoo M, et al. Biochem Biophys Res Commun. 2008 Nov 7;376(1):96-9. doi: 10.1016/j.bbrc.2008.08.092. Epub 2008 Aug 28. Biochem Biophys Res Commun. 2008. PMID: 18760995

7

Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research.

Yoo M, Park TH, Yoo M, Kim Y, Lee JY, Lee KM, Ryu SE, Lee BI, Jung KY, Park CH. Yoo M, et al. Molecules. 2021 Mar 17;26(6):1686. doi: 10.3390/molecules26061686. Molecules. 2021. PMID: 33802888 Free PMC article.

8

A natural compound, aristoyagonine, is identified as a potent bromodomain inhibitor by mid-throughput screening.

Kim YH, Kim M, Yoo M, Kim JE, Lee HK, Heo JN, Lee CO, Yoo M, Jung KY, Yun CS, Moon SW, Chang HK, Chung CW, Pyo S, Choi SU, Park CH. Kim YH, et al. Among authors: yoo m. Biochem Biophys Res Commun. 2018 Sep 5;503(2):882-887. doi: 10.1016/j.bbrc.2018.06.091. Epub 2018 Jun 20. Biochem Biophys Res Commun. 2018. PMID: 29928885

9

Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors.

Park SJ, Kim E, Yoo M, Lee JY, Park CH, Hwang JY, Ha JD. Park SJ, et al. Among authors: yoo m. Bioorg Med Chem Lett. 2017 Sep 15;27(18):4399-4404. doi: 10.1016/j.bmcl.2017.08.018. Epub 2017 Aug 12. Bioorg Med Chem Lett. 2017. PMID: 28827110

10

Synthesis and biological evaluation of indazole-4,7-dione derivatives as novel BRD4 inhibitors.

Yoo M, Yoo M, Kim JE, Lee HK, Lee CO, Park CH, Jung KY. Yoo M, et al. Arch Pharm Res. 2018 Jan;41(1):46-56. doi: 10.1007/s12272-017-0978-y. Epub 2017 Nov 4. Arch Pharm Res. 2018. PMID: 29103140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year